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Abstract
Background: Recent studies hypothesized left ventricular (LV) twist as a potential biomarker for evaluation of sub
clinical myocardial disease, however its relationship with aortic stiffness has yet to be investigated. Chronic kidney
disease (CKD) has been identified as a risk factor for both myocardial and arterial disease. As such we sought to explore
the relationship between aortic stiffness and LV twist in CKD patients without known cardiovascular disease (CVD).
Methods: In this prospective, observational study we enrolled 106 CKD patients (Stages 1 to 5) with normal LVEF as
assessed by conventional echocardiography. Aortic stiffness was measured using aortic pulse wave velocity (aPWV). We
defined increased aPWV as ≥10 m/s. LV Twist was measured using two-dimensional speckle tracking echocardiography.
Results: Patients with increased aPWV had higher LV twist (p = 0.002) but similar LVEF (p = 0.486). Aortic PWV correlated
crudely with age (p < 0.001), the presence of diabetes (p < 0.001), hypertension (p < 0.001), eGFR (p < 0.001), LVMI
(p = 0.01), e/e’ (p < 0.001) and LV twist (p = 0.003). In multivariable analyses after adjusting for age, gender, cardiovascular
risk factors and hypertensive medication, aPWV was independently associated with LV twist (β = 0.163, p = 0.025).
Conclusions: Aortic stiffness independently associates with LV Twist in asymptomatic CKD patients. These findings suggest
a close interaction between LV twist mechanics and arterial remodeling even before CVD becomes clinically relevant.
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Background
Recent data suggests that chronic kidney disease (CKD)
patients develop both arterial and myocardial dysfunc-
tion at an early stage of the disease. Wang and colleagues
identified that increased arterial stiffness is evident as early
as CKD stage 2 [1]. Even though obstructive epicardial ath-
erosclerotic disease is not an uncommon finding in pa-
tients with advanced CKD, early atherosclerotic changes in
the macro- and microvasculature result in arterial stiffness
that subsequently leads to structural myocardial disease
[2, 3]. These pathophysiological features are manifested
by a high risk of lethal arrhythmias, congestive heart
failure and stroke [3]. Extensive research on methods
for assessing arterial stiffness has led to a consensus
that aortic pulse wave velocity (aPWV) should be
regarded as the ‘gold standard’ [4]. Aortic PWV has
been validated in a variety of clinical settings including in
CKD [5–7].
Panoulas et al identified Left Ventricular (LV) twist as
a potential marker of sub clinical LV systolic dysfunction
in CKD patients with normal ejection fraction, as mea-
sured by conventional 2D echocardiography [8]. Abnor-
mal LV twist values were seen as early as CKD stage 3.
LV twist refers to the systolic twisting motion resulting
from basal clockwise rotation and apical counter-clockwise
rotation (when viewed from the apex) [9]. Previous data at-
tribute up to 40 % of LV stroke volume to ventricular twist
dynamics [10]. Furthermore LV twist has proven to be a
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more sensitive marker of subtle myocardial dysfunction
when compared with conventional echocardiographic
methods, namely LV ejection fraction (LVEF) [11]. Twist
mechanics can be accurately assessed using speckle-
tracking echocardiography (STE), which has been validated
against magnetic resonance imaging (MRI) and sonomicro-
metry [12].
To date, no study has explored the relationship be-
tween arterial stiffness and LV twist mechanics. As CKD
has been identified as a risk factor for both arterial and
myocardial disease we aimed to explore this association
in this high-risk patient cohort.
Methods
Study population
A total of 123 consecutive patients with CKD stages 1 to
5 were enrolled from Imperial College Healthcare NHS
Trust renal outpatient clinics between 2011 and 2014.
Chronic kidney disease was defined on the basis of im-
paired eGFR plus microalbuminuria, present on at least
two occasions over three months or more. Patients with:
clinical or echocardiographic evidence of LV systolic dys-
function, significant valvular abnormalities (moderate or
severe), presence of atrial fibrillation or flutter, pulmonary
hypertension, congenital heart disease, cardiomyopathy,
pericardial disease or inadequate echocardiographic acous-
tic windows were excluded from this study. Written in-
formed consent was obtained from all participants. The
study was approved by the UK National Research Ethics
Committee Service (REC 10/H0704/81).
Data collection
The collection of anthropometric data included height
(cm), weight (kg), body mass index (BMI, kg/m2) and
body surface area (BSA, g/m2). Using a structured ques-
tionnaire and medical notes review we collected the fol-
lowing data: systolic and diastolic blood pressure, both
measured in the sitting position in mmHg, hypertension
(defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or
on antihypertensive treatment), diagnosis of diabetes,
treated hypercholesterolaemia (use of statin, fibrate or
ezetimibe), family history of ischaemic heart disease,
smoking status (current, ex, never) and detailed list of
current medication. Biochemical results were obtained
from the most recent renal clinic review (within 1 month
of recruitment) provided that there was no evidence of
superimposed acute kidney injury during the time of
blood sampling. The value of eGFR was calculated using
the four-variable equation in the Modification of Diet in
Renal Disease study [13].
Echocardiographic assessment
Transthoracic echocardiography was performed using a
commercially available system (Vivid 7, GE Vingmed
Ultrasound, Horten, Norway) by a single, accredited
echocardiographer according to a standardised protocol.
All echocardiographic parameters were measured offline
in batches by one observer blinded to clinical and out-
come data. Interventricular septum thickness, posterior
wall thickness, LV mass index (LVMI), tissue Doppler
imaging S’ wave (TDI S’), left atrial (LA) dimension and
LVEF were measured according to the recommendations
of the American Society of Echocardiography [14].
2-dimensional speckle tracking echocardiography
Speckle tracking analysis was performed offline by the
customised software for Vivid (2D-strain EchoPac PC
v.7.0.1, GE Healthcare, Horten, Norway). Basal and apical
parasternal short axis views were recorded for each patient.
The basal plane was defined as that allowing visualization
of the mitral valve with the cross-section as circular as pos-
sible. The apical plane was acquired distally to the papillary
muscles [15]. LV twist was calculated as the net difference
in peak systolic rotational strain between the six basal and
six apical segments.
While acquiring two-dimensional images we kept the
focus position at intermediate depth and adjusted the
sector depth and width to include little but the region of
interest. Furthermore, the sampling region of interest
was adjusted to ensure that most of the wall thickness
was incorporated in the analysis avoiding the pericardium.
Frame rate was between 60 frames/s and 80 frames/s.
Arterial stiffness parameters
On the same day, around 10 min after performing the
echocardiogram, blood pressure was measured with the
subjects in supine position. Pressure waveforms were re-
corded on the radial, carotid and femoral arteries using
applanation tonometry [16]. Carotid-femoral aPWV was
calculated using a commercially available device (Sphyg-
moCor, Pulse Wave Analysis System, AtCor Medical),
with a high-fidelity Millar strain-gauge transducer (Millar
Instruments, Houston, TX) as described previously [6].
Two separate operators conducted the measurements
with coefficient of variation of <10 %.
Previous studies have demonstrated that a aPWV cut
off of 10 m/s has been shown to provide risk stratification
and prognostic value in CKD patients [17]. Therefore, in
our study we defined increased aPWV as ≥10 m/s.
Reproducibility
In order to test inter and intra-observer variability for
both LV Twist and aPWV indices, we reassessed the
measurements on a sub-group of 20 randomly selected
patients. Shortly after the first assessment a second oper-
ator, who was blinded to the results, analysed aPWV and
LV twist. Subsequently the first operator re-measured
the same indices.
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Statistical analysis
Statistical analysis was performed using SPSS software,
version 22 (IBM, Armonk, NY). Variables were tested
for normality by the Kolmogorov-Smirnov test. Firstly,
analysis was performed by dividing the patients into 2
groups; one with aPWV < 10 m/s and the other with
PWV ≥ 10 m/s. Differences between the 2 groups were
analyzed using chi-square test for categorical data, t-test
for continuous normally distributed data and Wilcoxon
rank sum test for continuous non-normally distributed data.
Correlations were assessed for normal and non-normal vari-
ables using Pearson’s and Spearman’s coefficients respect-
ively. Univariate and multivariate analyses were used to
evaluate the relationship between, arterial stiffness and a
range of variables including general demographics, cardio-
vascular risk factors, conventional echocardiographic and
speckle tracking parameters including LV Twist. Intraclass
correlation coefficients (ICC) and Bland-Altman plots were
determined to assess the inter-operator and intra-operator
variability of speckle tracking and arterial stiffness measure-
ments. The criterion for statistical significance used
was a P-value of ≤0.05 to a 95 % confidence interval.
Results
Inter- and intra-operator variability of speckle tracking and
arterial stiffness parameters
Inter-operator variability (n = 20): the ICC for LV twist
0.80, p < 0.001.
Intra-operator variability (n = 20): the ICC for LV twist
0.89, p < 0.001.
The strength of agreement for intra-observer and inter-
observer measurements of aPWV is shown in Fig. 1.
Figure 2 is a Bland-Altman plot showing inter-observer
variability of aPWV and LV Twist.
Feasibility of obtaining 2D speckle tracking deformation
indexes
Deformation parameters could not be quantified in 15 pa-
tients due to sub-optimal echodiagnostic windows (n = 9),
atrial fibrillation (n = 4) valvular abnormalities (n = 1) and
regional wall motion abnormalities (n = 1). A total of 106
patients were finally included in the study (Fig. 3).
Clinical and echocardiographic characteristics
95 CKD patients (89.6 %) underwent renal biopsy to de-
termine the cause of their CKD. The most common
CKD aetiology was diabetes (N = 30), followed by vascu-
litis (N = 18), post-renal causes (N = 10), IgA nephropathy
(N = 7), focal glomerulosclerosis (N = 6), membranous
glomerulonephritis (N = 5), hypertension (N = 4), adult
polycystic kidney disease (N = 3), renovascular disease
(N = 3), and minimal change disease (N = 3). In six pa-
tients, aetiology was unknown.
Patients were stratified in two different groups accord-
ing to aPWV: normal aPWV <10 m/s, increased aPWV ≥
10 m/s. Table 1 shows patients clinical characteristics.
Participants with increased aPWV were more likely to
have diabetes (p < 0.001) and hypertension (p < 0.001)
and lower eGFR (p < 0.001). Table 2 displays echocardio-
graphic parameters across the two groups. Patients with
increased aPWV had lower TDI S’ (p = 0.03), global lon-
gitudinal strain (GLS) (p = 0.002), higher LVMI (p = 0.01),
E/e’ (p = 0.01), LV Twist (p < 0.001)- Fig. 4 but similar
LVEF (p = 0.482). Table 3 shows the variation in LV Twist
and in aPWV as we move from early to late CKD stages.
Univariate association of aPWV with demographics, risk
factors and echocardiographic parameters
Table 4 displays univariate correlations of aPWV with
clinical and echocardiographic parametres. Aortic PWV
correlated crudely with age (p < 0.001), the presence of
diabetes (p < 0.001), hyperlipidemia (p = 0.013), peripheral
SBP (p < 0.001), hypertension (p < 0.001), eGFR (p < 0.001),
LVMI (p < 0.001), E/e’ (p < 0.001), TDI S’ (p = 0.03), GLS
(p = 0.01) and LV twist (p = 0.003). Figure 5 is a scatter plot
demonstrating the correlation between aPWV and LV
Twist.
Fig. 1 Intra-observer and inter-observer strength of agreement of aPWV (left) and Inter-class correlation of LV twist (right)
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Multivariable analysis
In the linear regression model, aPWV was independ-
ently associated with age (β = 0.467, p < 0.001), diabetes
(β = 0.532, p < 0.001), hypertension (β = 0.158, p = 0.05),
eGFR (β = -0.234, p = 0.008), LMVI (β = 0.143, p < 0.042)
and LV twist (β = 0.163, p = 0.025) Table 4.
Discussion
To our knowledge this is the first study to associate
aPWV, a marker of aortic stiffness, with LV twist, a myo-
cardial deformation index. The independent association
between LV twist and aPWV in asymptomatic CKD
patients, suggests an interplay between arterial and ven-
tricular mechanics early on in the cardiovascular disease
continuum.
Arterial remodeling has been described in early stage
CKD [18]. Compared with normotensive and hypertensive
controls, patients with CKD stages 2–5 had significantly
larger internal carotid artery diameters but comparable
intima-media thickness, resulting in significantly increased
circumferential wall stress [18]. Furthermore the recent
Nephrotest study [19] identified aPWV velocity as an in-
dependent predictor of all cause mortality and fatal or
non-fatal cardiovascular events in 439 patients with CKD
Fig. 2 Bland-Altman plot showing inter-observer variability of aPWV (left) and LV Twist (right)
Fig. 3 Feasibility in obtaining speckle tracking deformation parameters
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stages 3–5. The same study demonstrated that the
addition of PWV to traditional risk factors significantly
improved the risk stratification for all-cause mortality.
Arterial stiffness in early CKD patients has been associ-
ated with the presence of diastolic dysfunction [20] and
increased LV mass [21]. However its relationship with
systolic function remains poorly investigated and largely
unknown. Evaluation of systolic function in CKD patients
has traditionally been limited to volume-based assessment
of LVEF and assessment of regional wall motion or visual
estimation of regional thickening. Although LVEF is one
of the most powerful echocardiographic predictors of
death or cardiovascular morbidity is not a sensitive marker
of global LV systolic function in the presence of LV
hypertrophy (commonly present in CKD patients) [22].
Additionally, LVEF may be insufficiently sensitive to
identify mild degrees of systolic dysfunction as proven
by its inability to identify a gradation of risk in patients
with EF >45 % [23]. This suggests that asymptomatic
CKD patients can have myocardial dysfunction with pre-
served LVEF. Deformation imaging using STE may over-
come this limitation. Speckle tracking echocardiography
Table 1 Clinical characteristics according to aPWV groups
Normal PWV <10 m/s Increased PWV≥ 10 m/s p-value
n = 64 n = 42
Clinical demographics
Age 51.2 ± 14 63 ± 12 <0.001*
Male gender (%) 45.4 41.2 0.455
BSA (g/m2) 1.88 ± 0.21 1.87 ± 0.22 0.906
Cardiovascular risk factors
BMI (g/m2) 26.9 ± 5 27.8 ± 5.1 0.367
eGFR (mL/min/1.73 m2) 48.95 ± 20.1 30.5 ± 15.4 <0.001*
Systolic BP (mmHg) 127.2 ± 20.4 140.5 ± 18.5 0.01*
Diastolic BP (mmHg) 77.9 ± 10.6 79.5 ± 10.5 0.451
Diabetes (%) 20.3 71 <0.001*
Hypertension (%) 62.5 82.8 <0.001*
Family history of IHD (%) 29.7 26.8 0.755
Smoking status (%) Current
Current 6.3 9.8 0.295
Ex 9.4 9.8
Never 45.3 34.1
Medication
Aspirin (%) 28 37 0.367
Clopidogrel (%) 2 7 0.135
ACE-I (%) 34 69 <0.001*
ARBs (%) 53 51 0.858
Beta-blockers (%) 16 22 0.416
CCB dihydropyridine (%) 25 38 0.151
Loop diuretic (%) 22 34 0.112
Thiazide diuretic (%) 2 10 0.06
Any antihypertensive (%) 40.1 87.2
Statins (%) 61 80 0.110
Prednisolone (%) 22 10 0.125
Metformin (%) 9 18 0.081
Gliclazide (%) 9 12 0.649
Insulin (%) 8 41 <0.001*
BSA body surface area; BMI body mass index; GFR glomerular filtration rate, CKD chronic kidney disease; BP blood pressure; ARB angiotensin II receptor blocker;
CCB calcium channel blocker; IHD ischemic heart disease; ACE-I angiotensin-converting enzyme inhibitor; ARB angiotensin II receptor blocker
*Statistically significant difference between the two groups
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follows the motion of myocardial tissue throughout the
cardiac cycle by tracking acoustic reflections, known as
speckles, in previously obtained echocardiographic images.
Recently two studies explored the relationship of GLS, a
marker of subclinical systolic dysfunction and arterial stiff-
ness. Krishnasamy et al. demonstrated an independent as-
sociation between GLS, assessed by STE, and aPWV in
patients with CKD stages 3–5 [24]. Kim and colleagues
also found an independent association between brachial-
ankle PWV and GLS [25]. Concurring to our findings the
authors identified a close interaction between arterial stiff-
ness and LV function. However the aforementioned studies
are limited by the fact that novel elements of deformation
such as LV twist were not investigated.
Alterations in LV twist have been linked with subclin-
ical myocardial dysfunction in a variety of clinical settings
[26–28], nonetheless its association with arterial stiffness
has never been studied. To our knowledge the current
study is the first to find an independent association be-
tween LV twist and aPWV. With increased aPWV, the
reflected waves return earlier, impacting on the central
arteries during systole rather than diastole thus amplify-
ing aortic and ventricular systolic pressures. As a conse-
quence myocardial pressure load and oxygen consumption
Table 2 Echocardiographic characteristics according to aPWV groups
Normal PWV <10 m/s Increased PWV≥ 10 m/s p-value
n = 64 n = 42
Conventional echocardiography
Simpsons biplane EF (%) 62.9 ± 5 61.3 ± 4.7 0.48
TDI S’ – septal (cm/s) 10.6 ± 2.4 8.6 ± 1.9 0.03*
LVMI (g/m2) 63.7 ± 19 78.4 ± 22 0.01*
RWT 0.44 ± 0.09 0.51 ± 0.12 0.001*
E/e’ (average) 8.9 ± 3.7 10.8 ± 4.2 0.01*
LA (cm) 3.68 ± 0.58 3.9 ± 0.63 0.001*
Diastolic dysfunction (%)
Not present 40.6 22.5 0.001*
Type 1 50 40
Type 2 9.4 34.9
LV Twist (°) 19.8 ± 5.4 23.5 ± 5.7 <0.001*
GLS(%) −19.6 ± 3.3 −17.1 ± 2.9 0.002*
GCS(%) −23.3 ± 4.3 −22.8 ± 4.9 0.159
LVMI left ventricular mass index; RWT regional wall thickness; EF ejection fraction; LV left ventricle, GLS Global longitudinal strain; GCS Global circumferential strain
*Statistically significant difference between groups
Fig. 4 LV twist in a patient with normal and increased PWV
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increase, leading to subendocardial injury [2, 3]. Myocar-
dial fiber orientation changes continuously from a right-
handed helix in the subendocardium to a left-handed helix
in the subepicardial region [9]. Subepicardial layers domin-
ate the overall rotation/twist during ejection and remain
preserved in early myocardial disease [9]. Subendocardial
fibres counteract subepicardial dominance and are the
most vulnerable and sensitive to the presence of early
myocardial disease. Subendocardial injury would there-
fore exaggerate overall LV twist as the subepicardial fi-
bres would function in the absence of the counteracting
subendocardial ones. A similar mechanism has been
identified in patients with diastolic heart failure [29].
The current findings highlight that the cardiovascular
system should always be viewed as an entity. When
subclinical abnormalities are detected in the heart one
Table 3 Echocardiographic and arterial stiffness parameters across CKD stages
CKD stage 1/2 CKD stage 3 CKD stage 4/5 p valuea Adjusted p valueb
Simpsons biplane EF (%) 63.7 ± 5.5 62.3 ± 4.9 62.5 ± 4.9 0.617 0.838
LVMI (g/m2) 60.5 ± 20 70 ± 19.8 75.6 ± 24.1 0.003▪ 0.085▪
Concentric remodelling (%)RWT > 0.42 31 52.6 72.3 <0.001‡▪• <0.001‡▪•
E/e’ (average) 6.96 ± 2.25 9.41 ± 3.87 9.92 ± 3.96 <0.001‡ ▪ 0.013‡ ▪
TDI S’ - septal (cm/s) 11 ± 2.7 10.6 ± 3.7 9.1 ± 2.3 0.02▪• 0.03▪•
LV Twist (°) 18.5 ± 4.4 19.9 ± 5.4 24.6 ± 5.4 <0.001‡▪• <0.001‡▪•
PWV(m/s) 7.7 ± 2 10.3 ± 3.3 12.5 ± 4.2 <0.001‡▪• 0.001‡▪•
LVEF left ventricular ejection fraction; LVMI left ventricular mass index; RWT regional wall thickness; LV left ventricular; PWV pulse wave velocity
aStatistically significant difference between: ‡CKD stage 1/2 and CKD stage 3, ▪CKD stage 1/2 and CKD stage 4/5, •CKD stage 3 and CKD stage 4/5
bAdjusted for age, gender, diabetes, SBP, BMI, treated hyperlipidaemia, eGFR and family history of ischaemic heart disease
Table 4 Univariate and multivariate analysis of aPWV
Crude Adjusteda Adjustedb
Standardized β P -value Standardized β p-value Standardized β p-value
Age 0.635 <0.001* 0.492 <0.001* 0.467 <0.001*
Gender −0.172 0.079 −0.019 0.654 −0.013 0.691
BSA (g/m2) 0.27 0.187 0.031 0.238 0.345 0.459
Hemoglobin (g/L) −0.150 0.131 −0.059 0.481 −0.098 0.221
Hyperlipidemia 0.242 0.013* 0.118 0.144 0.065 0.433
Peripheral systolic BP (mmHg) 0.397 <0.001* 0.185 0.024* 0.169 0.059
Diabetes (%) 0.589 <0.001* 0.555 <0.001* 0.532 <0.001*
Hypertension (%) 0.308 <0.001* 0.294 0.013* 0.158 0.050*
BMI (g/m2) 0.055 0.579 −0.156 0.063 −0.133 0.118
eGFR (mL/min/1.73 m2) −0.410 <0.001* −0.259 0.003* −0.234 0.008*
Echocardiographic parameters
Simpsons biplane EF(%) −0.117 0.237 −0.036 0.646 −0.094 0.634
TDI S’ - septal (cm/s) 0.186 0.03 * 0.120 0.058 0.101 0.093
E/e’(average) 0.387 <0.001* 0.192 0.022* 0.113 0.089
LVMI (g/m2) 0.379 <0.001* 0.165 0.03* 0.143 0.042*
LV Twist(°) 0.388 0.003* 0.181 0.019* 0.163 0.025*
GLS(%) 0.300 0.01* 0.186 0.09 0.060 0.130
GCS(%) 0.046 0.197 0.018 0.458 0.010 0.634
Standardized coefficients (β) refer to how many SDs a dependent variable (aPWV) will change, per standard deviation increase in the predictor variable. n = 106
*statistically significant
CKD chronic kidney disease; BSA body surface area; BP blood pressure; LVMI left ventricular mass index; eGFR estimated glomerular filtration rate; EF ejection
fraction; LV left ventricular
aAdjusted for age, gender, diabetes, SBP, BMI, treated hyperlipidaemia, eGFR and family history of ischaemic heart disease
bAdjusted for factors in Model 2 plus antihypertensive medication (b-blockers, dihydropyridine calcium channel blockers, ACE inhibitors, angiotensin II receptor
blockers) and prednisolone
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should also consider exploring the presence of early
disease in the peripheral arterial system and vice versa.
Patients with isolated hypertension [30], heart failure
with normal LVEF [31], diabetes mellitus [32] or CKD
[2] could potentially benefit of STE or aPWV for early
identification of CVD. However, it should be noted that
although STE has been validated against sonomicrome-
try and CMR, vendor reproducibility [33], the need for
optimal image quality and time constraint are limiting
STE use in routine clinical practice. However, strain
imaging using STE could be used as a supplementary
diagnostic method in several conditions [34]; (i) to identify
early systolic dysfunction in patients with normal or pre-
served LVEF [8, 35], (ii) to identify subclinical LV dysfunc-
tion in individuals who are evaluated for cardiomyopathy
[36], (iii) in addition to LVEF in patients undergoing
chemotherapy to identify sub-clinical LV dysfunction [37].
Future randomized control studies are required to assess
the potential benefit of early, aggressive risk factor man-
agement in asymptomatic CKD patients with abnormal
LV twist/aPWV indices. For the time being, physicians
should consider initiation of risk factor modification ther-
apies in CKD patients with abnormal LV twist or PWV
parameters, even in the absence of high CVD risk using
established calculators (Q-risk, Framingham, etc).
Limitations
Firstly due to the observational design of the study we
cannot determine causality between subclinical 2DSTE
abnormalities and aPWV and our results should be viewed
as hypothesis generating. Secondly, even though patients
recruited in the current study were asymptomatic from
the cardiovascular point of view, with no previous history
of ischaemic heart disease and a structurally normal
heart on transthoracic echocardiogram, the presence of
significant coronary artery disease was not ruled out with
a functional or invasive test. However, in a subset of 20
pre-dialysis patients who subsequently underwent elective
invasive angiography as part of their pre-transplant assess-
ment, the vast majority 19 (95 %), had no significant dis-
ease in their epicardial arteries. This fact supports the
hypothesis that microvascular ischaemia may be ac-
countable for the LV twist patterns observed in our
CKD population.
Conclusions
In summary the current study provides for the first time
a link between LV twist assessed by STE and early periph-
eral arterial disease, in asymptomatic CKD patients with
preserved LVEF. Future studies of patients with these
early subclinical markers of CVD should be undertaken,
randomizing their participants to aggressive risk factor
management versus watchful waiting. If early risk factor
modification in patients with abnormal LV twist and PWV
values improves outcomes, these markers could be used
for risk stratification purposes in this population.
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